Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Trimegah Bangun Persada Tbk. (NCKL) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Trimegah Bangun Persada Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Trimegah Bangun Persada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp885 (market cap 54.26T, 56.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 314× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (56.47M versus 592.2K). Which is the better fit depends on your goals.

NCKLOBAT
Market Cap
54.26T172.82B
Volume
56.47M592.2K
Lot
564.68K5.92K
Turnover
50.19B147.05M
Average Price
888.82248.31
Value
50.19B147.05M
Indicative Equilibrium Price
885254
Indicative Equilibrium Volume
11.61K10

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NCKL
View details
OBAT
View details

About Trimegah Bangun Persada Tbk.

PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.

Read more on NCKL

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT